Registration Options

Activity Dates: 04/27/2020 - 04/27/2023

Members can access this product for only $35. Log in or Join now!

Target Audience

This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

In the US, deaths due to suicide and unintentional overdose are on the rise and pose an urgent public health concern. In 2017, over 40% of suicide and overdose deaths, so-called “Deaths of Despair”, were due to opioids. This represents a 2-1/2 fold increase from 17% in 2000.1 Pain alters neurocircuitry and increases the risk of suicide, which may be unknown to many psychiatric pharmacists. There are several key shared risk factors and prevention approaches that should be known by psychiatric pharmacists. By understanding these key risk factors, pharmacists can better identify patients at greatest risk. By learning key prevention approaches, pharmacists can intervene and save the lives of patients in their care by preventing unintentional overdoses and deaths by suicide.

As a response to legislation and other pressures, many patients are having opioid therapy rapidly tapered or abruptly terminated by their providers. Many psychiatric pharmacists may be unfamiliar with various opioid tapering strategies and which is best for a given patient. Knowledge of the principles of compassionate opioid tapering can help pharmacists treat patients and educate other providers about best opioid practices.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Sign in (or create a FREE account).
  • Register for this course. (sign in first)
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (sign in first)
  • Complete the evaluation at the end of the activity. (sign in first)
  • If necessary, complete the post-test retest no later than the closing activity date. (sign in first)
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (sign in first)

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information and Disclosures

Learning Objectives

  1. Evaluate the links between opioid use, chronic pain, suicide, and the subsequent impact on patient care.
  2. Describe prevention strategies for unintentional opioid overdose and suicide.
  3. Disseminate knowledge on the principles of ethical and compassionate opioid tapering aimed at reducing unintentional overdose and suicide.

Continuing Education Credit and Disclosures

Activity Dates: 04/27/2020 - 04/27/2023
ACPE Contact Hours: 1
ACPE Number: 0284-0000-20-016-H08-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.